ITIF：2026年美国如何减少对中国活性药物成分（APIs）的依赖报告（英文版）

In 1981, Europe produced 63 percent of APIs and the United States 25 percent. By 2024, China had produced 45 percent and India 43 percent, as the European and U.S. shares fell to 6 percent and 3 percent, respectively.  U.S. dependence on China for APIs reflects decades of cost-driven offshoring and upstream concentration, creating structural vulnerabilities in the supply of essential medicines.  Reducing dependence on Chinese APIs will require a multifaceted strategy that combines strategic